Finance

Lists
TORNTPHARM:NSE
Torrent Pharmaceuticals Ltd
₹ ४,७७२.५०
-०.५७%
(-२७.५०) 1D
अक्टोबर १, १५:३०:०० GMT+५:३०  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for TORNTPHARM...
Open
₹ ४,८००.००
High
₹ ४,८१०.५०
Low
₹ ४,७१७.३०
Mkt. cap
१६.१२ खरब
Avg. vol.
३.३२ लाख
Volume
३.५८ लाख
Dividend
०.८०%
Quarterly dividend
₹ ९.५०
Ex-dividend date
२०२६ मे २९
P/E ratio
७६.२४
52-wk high
₹ ५,२५०.००
52-wk low
₹ ३,४८०.६०
EPS
₹ ६२.६०
Shares outstanding
१७.०० करोड
No. of employees
१८ हजार
Open
₹ ४,८००.००
High
₹ ४,८१०.५०
Low
₹ ४,७१७.३०
Mkt. cap
१६.१२ खरब
Avg. vol.
३.३२ लाख
Volume
३.५८ लाख
Dividend
०.८०%
Quarterly dividend
₹ ९.५०
Ex-dividend date
२०२६ मे २९
P/E ratio
७६.२४
52-wk high
₹ ५,२५०.००
52-wk low
₹ ३,४८०.६०
EPS
₹ ६२.६०
Shares outstanding
१७.०० करोड
No. of employees
१८ हजार
News stories
From web sources and news partners
Yahoo Finance
Yahoo Finance
·
१ घण्टा पहिले
4 Stocks Delivered About Half of the S&P 500's Gain This Year
TradingView
TradingView
·
१ घण्टा पहिले
News by CNBC TV18 on TradingView, 2026-10-03 — cnbctv:97a9b14b1094b:0
U.Today
U.Today
·
२६ मिनेट पहिले
XRP to $2? Analyzing How Nasdaq Listing Could Impact Token Price
Profile
Torrent Pharmaceuticals Ltd, d/b/a Torrent Pharma, is an Indian multinational pharmaceutical company, part of the Torrent Group and headquartered in Ahmedabad. It was promoted by U. N. Mehta, initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd. Torrent Pharmaceuticals operates in more than 40 countries with over 2,000 product registrations globally. Torrent Pharma is active in the therapeutic areas of cardiovascular, central nervous system, gastro-intestinal, diabetology, anti-infective and pain management segments. It also has a presence in therapeutic segments of nephrology, oncology, gynecology, respiratory and pediatrics. Wikipedia
About Torrent Pharmaceuticals Ltd
CEO-
Employees१८.३ हजार
Founded१९५९
Headquartersअहमदाबाद, गुजरात, भारत
Sector-
Last report
२०२६ जुलाई ३०
Fiscal period
Q1 2027
EPS / Est. (INR)
₹ १५.३० / ₹ १६.२०
-५.५५%miss
Revenue / Est. (INR)
४९.२१ अरब / ४७.२९ अरब
+४.०७%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
३३.०२ अरब
३३.०३ अरब
४१.९७ अरब
४९.२१ अरब
Cost of goods sold
८.०० अरब
७.९९ अरब
१०.१५ अरब
११.६३ अरब
Cost of revenue
८.०० अरब
७.९९ अरब
१०.१५ अरब
११.६३ अरब
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
६.२७ अरब
६.५१ अरब
८.४८ अरब
८.९३ अरब
Operating expense
१६.२३ अरब
१६.२२ अरब
२३.३४ अरब
२६.८७ अरब
Total operating expenses
२४.२३ अरब
२४.२१ अरब
३३.४९ अरब
३८.५० अरब
Operating income
८.७९ अरब
८.८२ अरब
८.४८ अरब
१०.७१ अरब
Other non operating income
-२७.०० करोड
-१३.०० करोड
७९.४४ करोड
-१२.०० करोड
EBT including unusual items
७.९१ अरब
८.१४ अरब
५.२९ अरब
७.३३ अरब
EBT excluding unusual items
८.०४ अरब
८.२४ अरब
५.४७ अरब
७.५४ अरब
Income tax expense
२.०० अरब
१.७९ अरब
१.६५ अरब
१.६७ अरब
Effective tax rate
२५.२८%
२१.९९%
३१.१८%
२२.७८%
Other operating expenses
७.९२ अरब
७.६५ अरब
९.७८ अरब
१२.०१ अरब
Net income
५.९१ अरब
६.३५ अरब
३.८९ अरब
५.६६ अरब
Net profit margin
१७.९०%
१९.२२%
९.२८%
११.५०%
Earnings per share
१७.७५
१९.००
१२.८५
१५.३०
Interest and investment income
-
-
३८.४३ करोड
-
Interest expense
-४८.०० करोड
-४५.०० करोड
-२.३६ अरब
-३.०५ अरब
Net interest expenses
-४८.०० करोड
-४५.०० करोड
-१.९७ अरब
-३.०५ अरब
Depreciation and amortization charges
२.०४ अरब
२.०६ अरब
५.०८ अरब
५.९३ अरब
EBITDA
१०.८२ अरब
१०.६९ अरब
११.१२ अरब
१३.३५ अरब
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google एपहरू